{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:23:52Z","timestamp":1760549032269},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In differentiated thyroid carcinoma (DTC) with primary tumor smaller than 1 cm, the routine central lymph node (LN) dissection is questioned, due to increased risk of post-surgery complications and lack of confirmed benefit.<\/jats:p>\n          <jats:p>\n            <jats:bold>Aim<\/jats:bold>\n          <\/jats:p>\n          <jats:p>The analysis of prognostic significance of LN metastases, in DTC patients to verify the potential role of central neck lymphadenectomy on disease staging.<\/jats:p>\n          <jats:p>\n            <jats:bold>Materials and methods<\/jats:bold>\n          <\/jats:p>\n          <jats:p>The group of 195 DTC patients, primarily operated between 2004 and 2005, was retrospectively analyzed. 184 patients after radical operation, with no distant metastases diagnosed before surgery, were included into analysis. LN metastases were observed in 55 of cases (28%). In 124 cases only dissection of central LN compartment was performed, in 36 patients also uni- or bilateral modified cervical lymphadectomy was carried out. In 24 patients with tumor limited to the thyroid gland without suspicious lymph nodes, the routine central lymph node dissection was not done.<\/jats:p>\n          <jats:p>\n            <jats:bold>Results<\/jats:bold>\n          <\/jats:p>\n          <jats:p>Median follow-up was 4 years. The 5-year overall and disease free survival standardized ratio were 100% and 95% respectively. The risk of LN metastases increased with the more locally advanced cancer. In the group of 124 patients, in whom only central LN dissection was performed, LN metastases were diagnosed in 15 cases (12%). No significant relation between multifocality and frequency of central and\/or lateral LN metastases was noticed. Significant correlation between N feature and extrathyroidal invasion was observed (p = 0,0003). The presence of LN metastases was related to worsening of disease free survival from 99 to 90%. During the follow-up recurrence occurred in 6 (3%) cases. In 24 patients in whom only total thyroidectomy was done, no local or distant recurrence was observed. The assessment of early postoperative complications (hypoparathyroidism, paresis of vocal cords) indicated that the frequency of early calcium balance disturbances was significantly lower in patients in whom central LN dissection was not performed (p = 0,04)<\/jats:p>\n          <jats:p>\n            <jats:bold>Conclusions<\/jats:bold>\n          <\/jats:p>\n          <jats:p>Our result indicate that in the early diagnosis of thyroid cancer, the occurrence of LN DTC metastases is rarer and was observed only in 12% of elective dissections of central LN node compartment, if no lateral dissection was indicated due to the lack of clinical suspicion. In DTC patients with tumor diameter &lt;1 cm and no sonographical or inraoperative suspicion on LN involvement, routine central lymphadenectomy may be not obligatory.<\/jats:p>","DOI":"10.1186\/1756-6614-3-8","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T18:14:51Z","timestamp":1288376091000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision"],"prefix":"10.1186","volume":"3","author":[{"given":"Agnieszka","family":"Czarniecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Jarzab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Krajewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Chmielik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogna","family":"Szcze\u015bniak-Klusek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Stobiecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kokot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanis\u0142aw","family":"Poltorak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Wloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,29]]},"reference":[{"issue":"6","key":"28_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.surg.2008.08.034","volume":"44","author":"V Zaydfudim","year":"2008","unstructured":"Zaydfudim V, Feurer ID, Griffin MR, Phay JE: The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008,44(6):1070\u20137. discussion 1077\u20138 10.1016\/j.surg.2008.08.034","journal-title":"Surgery"},{"issue":"8","key":"28_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00268-002-6668-y","volume":"26","author":"J Witte","year":"2002","unstructured":"Witte J, Goretzki PE, Dieken J, Simon D, Roher HD: Importance of lymph node metastases in follicular thyroid cancer. World J Surg 2002,26(8):1017\u20131022. 10.1007\/s00268-002-6668-y","journal-title":"World J Surg"},{"issue":"1","key":"28_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00268-001-0176-3","volume":"26","author":"A Machens","year":"2002","unstructured":"Machens A, Hinze R, Thomusch O, Dralle H: Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002,26(1):22\u201328. 10.1007\/s00268-001-0176-3","journal-title":"World J Surg"},{"issue":"9","key":"28_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1089\/105072501316973145","volume":"11","author":"F Pacini","year":"2001","unstructured":"Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, Agate L, Bottici V, Raffaelli M, Pinchera A: Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001,11(9):877\u2013881. 10.1089\/105072501316973145","journal-title":"Thyroid"},{"key":"28_CR5","volume-title":"Indication for less than total thyroidectomy in differentiated thyroid cancer","author":"A Czarniecka","year":"2004","unstructured":"Czarniecka A: Indication for less than total thyroidectomy in differentiated thyroid cancer. Zabrze, Poland Silesian Medical University; 2004."},{"issue":"6","key":"28_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0039-6060(98)70034-0","volume":"124","author":"B Cady","year":"1998","unstructured":"Cady B: Presidential address: beyond risk groups--a new look at differentiated thyroid cancer. Surgery 1998,124(6):947\u2013957.","journal-title":"Surgery"},{"issue":"6","key":"28_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/110241501750243734","volume":"167","author":"S Ortiz","year":"2001","unstructured":"Ortiz S, Rodriguez JM, Parrilla P, Perez D, Moreno-Gallego A, Rios A, Soria T: Recurrent papillary thyroid cancer:analysis of prognostic factors including the histological variant. Eur J Surg 2001,167(6):406\u2013412. 10.1080\/110241501750243734","journal-title":"Eur J Surg"},{"issue":"5","key":"28_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2265.1999.00715.x","volume":"50","author":"I Tzavara","year":"1999","unstructured":"Tzavara I, Vlassopoulou B, Alevizaki C, Koukoulis G, Tzanela M, Koumoussi P, Sotsiou F, Thalassinos N: Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece. Clin Endocrinol (Oxf) 1999,50(5):643\u2013654. 10.1046\/j.1365-2265.1999.00715.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"28_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/BF02483006","volume":"29","author":"T Kobayashi","year":"1999","unstructured":"Kobayashi T, Asakawa H, Komoike Y, Tamaki Y, Monden M: Characteristics and prognostic factors in patients with differentiated thyroid cancer who underwent a total or subtotal thyroidectomy: surgical approach for high-risk patients. Surg Today 1999,29(3):200\u2013203. 10.1007\/BF02483006","journal-title":"Surg Today"},{"issue":"4","key":"28_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","volume":"86","author":"EL Mazzaferri","year":"2001","unstructured":"Mazzaferri EL, Kloos RT: Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001,86(4):1447\u20131463. 10.1210\/jc.86.4.1447","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"28_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0002-9610(99)00254-8","volume":"179","author":"S Beenken","year":"2000","unstructured":"Beenken S, Roye D, Weiss H, Sellers M, Urist M, Diethelm A, Goepfert H: Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg 2000,179(1):51\u201356. 10.1016\/S0002-9610(99)00254-8","journal-title":"Am J Surg"},{"issue":"3","key":"28_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00104-007-1303-y","volume":"78","author":"O Gimm","year":"2007","unstructured":"Gimm O, Dralle H: Lymphadenectomy for thyroid and lymph node carcinomas. Chirurg 2007,78(3):182. 184\u20138,190\u20133 10.1007\/s00104-007-1303-y","journal-title":"Chirurg"},{"issue":"6-7","key":"28_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.anchir.2005.10.009","volume":"131","author":"M Mathonnet","year":"2006","unstructured":"Mathonnet M: Lymph node dissection in non-medullary differentiated thyroid carcinoma. Ann Chir 2006,131(6\u20137):361\u20138. 10.1016\/j.anchir.2005.10.009","journal-title":"Ann Chir"},{"issue":"5","key":"28_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004230050148","volume":"383","author":"B Mann","year":"1998","unstructured":"Mann B, Buhr HJ: Lymph node dissection in patients with differentiated thyroid carcinoma--who benefits? Langenbecks Arch Surg 1998,383(5):355\u20138. 10.1007\/s004230050148","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"28_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s00104-008-1489-7","volume":"79","author":"C Vorl\u00e4nder","year":"2008","unstructured":"Vorl\u00e4nder C, Lienenl\u00fcke RH, Wahl RA: Lymph node dissection in papillary and follicular thyroid cancer. Chirurg 2008,79(6):564\u201370. 10.1007\/s00104-008-1489-7","journal-title":"Chirurg"},{"issue":"4","key":"28_CR16","first-page":"2439","volume":"24","author":"M Bononi","year":"2004","unstructured":"Bononi M, Tocchi A, Cangemi V, Vecchione A, Giovagnoli MR, De Cesare A, Fiori E, Volpino P, Brozzetti S, Meucci M, Scozzafava S, Cavallaro : Lymph node dissection in papillary or follicular thyroid carcinoma. Anticancer Res 2004,24(4):2439\u201342.","journal-title":"Anticancer Res"},{"issue":"5","key":"28_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00423-008-0360-0","volume":"393","author":"N Palestini","year":"2008","unstructured":"Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A: Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg 2008,393(5):693\u20138. 10.1007\/s00423-008-0360-0","journal-title":"Langenbecks Arch Surg"},{"issue":"1-2","key":"28_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mce.2010.01.007","volume":"322","author":"D Handkiewicz-Junak","year":"2010","unstructured":"Handkiewicz-Junak D, Czarniecka A, Jarzab B: Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions. Mol Cell Endocrinol 2010,322(1\u20132):8\u201328. 10.1016\/j.mce.2010.01.007","journal-title":"Mol Cell Endocrinol"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-6614-3-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:15:41Z","timestamp":1630469741000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/1756-6614-3-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,29]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1186\/1756-6614-3-8","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,29]]},"assertion":[{"value":"26 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}